Today Implant related diseases will affect between 30 to 60% of the implants placed worldwide a few years after placement. Depending on the severity, they might require some basic action up to surgical treatment to try to save the implant structure, that, we believe, should be saved whenever possible, avoiding traumatic and economic consequences over a big period of time for the patient.
A key question is when to utilize the surgical route to solve the problems, and several studies have tackled that
«The most important determinants of successful outcomes when using nonsurgical mechanical debridement to treat peri-implant lesions are the initial depth of the lesions, the amount of bone loss associated with the lesions, and the ability to fully debride implant surfaces.
Nonsurgical therapy appears most effective when the lesion is confined solely to the soft tissue at sites with no bone loss. A consensus has not been achieved with regard to nonsurgical therapy when bone loss has occurred. Some studies suggest that nonsurgical interventions are effective when bone loss is present, but only when it is less than 25% of the implant length.»
At MTD we are convinced that the principles to treat these lesions are very similar, but the tools vary as well as the doses, so, based on that conviction we have created a product for the non-surgical treatments and developed a full kit for when a surgery is unavoidable.